Inventor · disambiguated record
Hilde Lavreysen
Also filed as: LAVREYSEN HILDE
6 granted patents·3 pending applications·7 citations·filing 2003–2024
74Inventor score
Files withJANSSEN PHARMACEUTICA NV9
Top patents by PatentIndex Score
9 records- 0186US2025288584A1Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0285US2025041301A1Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0380US9708315B21,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 18, 2017·5 cites·5 claims
- 0479US11369606B2Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 28, 2022·1 cites·20 claims
- 0576US12048696B2Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jul 30, 2024·0 cites·24 claims
- 0676US11103506B2Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Aug 31, 2021·0 cites·14 claims
- 0775US2022143141A1Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0871US10537573B2Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their useJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jan 21, 2020·1 cites·20 claims
- 0948US7517517B2Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligandsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Apr 14, 2009·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Hilde Lavreysen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →